Sam Guglani has created the most thoughtful and provocative space for invention and artistry in medicine today. Medicine Unboxed is uniquely unique. We have much to thank Sam for. And he is also a genuinely lovely human being.

The incomparable Raja Shehadeh: please read his words and think of the horror we have witnessed—and our governments have sanctioned. theguardian.com/commentisfree/…

In six months in Gaza, Israel's worst-ever war achieved nothing but death and destruction haaretz.com/opinion/2024-0….

Prostate cancer presents an especially huge challenge to low/middle income countries.

And the surge in deaths.

Ian Tannock: Prepare for the surge in cases of prostate cancer.

Action 4—Invest in research, especially to understand the effects of ethnic differences.

Action 3—Implement (and ensure adherence to) pragmatic practice recommendations tailored to individual national settings.

Action 2—Facilitate use of AI to address deficits in health workforce.

The Lancet Commission on Prostate Cancer: Action 1—Improve diagnostic pathways.

In LMICs, late diagnosis is the central challenge.

The projected increase in prostate cancer cases is phenomenal and will put huge pressure on health systems worldwide.

Prostate cancer is not preventable.

Vania Wisdom, The Lancet’s Oncology Ambassador, explains the purpose of a Lancet Commission: to turn science into action.

Peter Albers opens by stressing the role of patients in shaping the future of cancer care and policy.

If you are in Paris at 5.15 pm today with nothing else to do in the sunshine, think about coming to our public launch of The Lancet Commission on Prostate Cancer. You won’t regret it.

Nick James The Commission report calls for, among other actions, programmes to raise awareness of #ProstateCancer + improvements in early diagnosis & treatment in LMICs – where most men present with late-stage disease. hubs.li/Q02rWL2D0

Prostate cancer is the most common cancer in men in over 100 countries worldwide. This burden will increase and is not avoidable. Ageing and genetics are the major determinants. The Lancet commission on Prostate cancer makes a plan on how to prepare for the surge of new cases👇

Prostate cancer cases are expected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, new analysis suggests.

More from the Lancet Commission on #ProstateCancer in-thread 🧵

▶️ hubs.li/Q02r1b720

Offline: The death of civilian immunity. “The ignominy is on us all.” thelancet.com/journals/lance…